Best Peptides for Muscle Growth
This category needs a caveat before the ranking, because the honest version of this article disagrees with most of what is written about it. No peptide is a reliable muscle builder in the way anabolic steroids are, and the research on growth hormone in healthy adults is considerably less impressive than the marketing suggests.
The ranking
| # | Compound | Mechanism | Realistic effect | Evidence |
|---|---|---|---|---|
| 1 | CJC-1295 + ipamorelin | GHRH analogue + ghrelin agonist | Recovery, sleep, body composition at the margin | GH elevation confirmed; muscle outcomes not |
| 2 | Sermorelin | GHRH analogue | Similar, milder and shorter-acting | Approved historically for GH deficiency |
| 3 | BPC-157 | Tissue repair, angiogenesis | Injury recovery — indirect route to training more | Strong animal data, no human trials |
| 4 | TB-500 | Actin regulation, cell migration | Soft tissue recovery | Animal and veterinary data |
| 5 | IGF-1 LR3 | Direct IGF-1 receptor agonism | Most direct anabolic signal — and the least characterized | Minimal human data |
| 6 | Tesamorelin | GHRH analogue | Visceral fat reduction, not muscle | Approved for lipodystrophy |
1. CJC-1295 + ipamorelin — the sensible default
The pairing works because the two compounds hit different receptors in the same pathway: CJC-1295 increases the releasable GH pool via the GHRH receptor, ipamorelin triggers release via the ghrelin receptor. Ipamorelin is selective enough not to meaningfully raise cortisol or prolactin, which is why it displaced older secretagogues like GHRP-6.
What to expect, stated honestly: better sleep quality is the most consistent report, along with recovery and modest body composition change. What not to expect: the lean mass gain pattern people associate with anabolics. Full mechanism, DAC-versus-no-DAC comparison and blend vial math are in our CJC-1295 and ipamorelin guide.
CJC-1295 + Ipamorelin blend — American Peptides
Available as 5/5 mg and 10/10 mg blends and as separate vials. Batch COA with HPLC and mass spec. Research use only.
We may earn a commission if you buy through this link (at no extra cost to you). Sold for research purposes only.
2. Sermorelin — the milder relative
Sermorelin is GHRH(1-29), the shortest active fragment of natural GHRH, and it has genuine pharmaceutical history: it was approved for diagnostic use and for GH deficiency in children before being discontinued commercially. Its half-life is very short, so it produces a clean pulse and little else. Less potent than CJC-1295, and better characterized.
3–4. BPC-157 and TB-500 — recovery, not growth
Neither is anabolic. They belong in this article because injury is what actually stops most people from training, and both have repair-focused evidence — BPC-157 with a deep rodent literature on tendon, ligament and muscle healing, TB-500 with animal and veterinary work on soft tissue. The indirect route to more muscle is training uninterrupted.
Read the caveats before deciding: our BPC-157 guide covers the unresolved angiogenesis question, and the TB-500 guide explains why evidence about thymosin beta-4 is not evidence about the fragment being sold.
5. IGF-1 LR3 — the one to be most careful with
IGF-1 is the mediator through which much of GH's anabolic effect actually happens, and the Long R3 variant has a dramatically extended half-life compared with native IGF-1. On paper that makes it the most direct option in this list.
In practice it is the least characterized. Sustained supraphysiological IGF-1 bypasses the feedback mechanisms that normally cap it, IGF-1 is a growth factor with well-documented relevance to tumor biology, and human safety data for LR3 specifically is essentially absent. Hypoglycaemia is also a real acute concern given IGF-1's insulin-like activity. The combination of strong signal and no safety data is exactly the profile that warrants caution.
6. Tesamorelin — different target
Included to correct a common miscategorisation. Tesamorelin is an approved GHRH analogue, but its indication and evidence are about reducing visceral fat in HIV-associated lipodystrophy, not building muscle. It is a legitimate drug for a specific purpose that is not this one.
What the evidence actually supports
If the goal is muscle, the honest hierarchy puts progressive resistance training first, adequate protein and calories second, and sleep third — each with vastly more supporting evidence than anything on this page. Peptides in this category sit at the margin, and their most defensible use is recovery rather than growth.
One more practical point: everything here is prohibited by WADA at all times. If you compete in a tested sport, this entire category is off the table regardless of the evidence.
Frequently asked questions
Do peptides actually build muscle?
Growth hormone secretagogues reliably raise GH and IGF-1, and studies of growth hormone in healthy adults show it increases lean body mass — but much of that is water and connective tissue rather than contractile muscle, and GH alone does not meaningfully increase strength. No peptide has been shown to build muscle the way resistance training and adequate protein do.
Which peptide is best for muscle growth?
By mechanism and available evidence, the CJC-1295 and ipamorelin pairing is the most sensible option in this category — it raises GH through the body's own pulsatile pathway. It is best understood as supporting recovery and body composition at the margin, not as an anabolic agent.
Is IGF-1 LR3 stronger than growth hormone peptides?
It acts more directly, since IGF-1 is the downstream mediator of much of GH's anabolic effect, and LR3 has a far longer half-life than native IGF-1. That directness is also the risk: it bypasses the feedback loops that limit GH-driven IGF-1 elevation, and it has essentially no human safety data.
Are these peptides banned in sport?
Yes. Growth hormone secretagogues including CJC-1295, ipamorelin and sermorelin, plus IGF-1 and its analogues, are prohibited by WADA at all times under the peptide hormones and growth factors categories.
Sources
- Liu H et al. Systematic review: the effects of growth hormone on athletic performance. Annals of Internal Medicine, 2008;148(10):747–58. PubMed
- Teichman SL et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism, 2006;91(3):799–805. PubMed
- Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 1998;139(5):552–61. PubMed
- Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sexual Medicine Reviews, 2018;6(1):45–53. PubMed
- Chang CH et al. The promoting effect of BPC 157 on tendon healing. Journal of Applied Physiology, 2011;110(3):774–80. PubMed
- World Anti-Doping Agency. Prohibited List 2026 — section S2 (peptide hormones, growth factors; S2.2.4 names CJC-1295 and ipamorelin) and section S4 (hormone and metabolic modulators). WADA Prohibited List
Related guides
- CJC-1295 & ipamorelin: dosage and side effects
- BPC-157 side effects and dosage
- TB-500 guide
- Where to buy peptides